Background Inflammation has been implicated in core features of depression
pathophysiology and treatment resistance. Therefore, new challenges in the discovery of …

Currently, diagnosis and treatment of major depressive disorder (MDD) are based on the
patients' description of symptoms, mental status examinations, and clinical behavioral …

Depression is a debilitating mental illness that affects up to 120 million people worldwide; it
is currently determined based on subjective diagnostic schemes that are limited by high …

Background and objectives Accumulating evidence suggests that exosomal miRNAs play
important roles in disease pathogenesis; however, their role in the pathogenesis of …

Objective Major depressive disorder (MDD) is a recurrent disorder with an increasing
incidence. Alterations in key signaling pathways of the nervous system, such as the Wnt and …

Major Depressive Disorder (MDD) represents a major global health concern, a body-mind
malady of rising prevalence worldwide nowadays. The complex network of mechanisms …

Background: Major depressive disorder (MDD) is a serious and common psychiatric
disorder with a high prevalence in the population. Although great advances have been …

Background and Objectives: Currently, there is a serious need to find practical biomarker (s)
for Major Depressive Disorder (MDD) therapeutic target (s). This study aimed to investigate …

Background: Depression is a common medical condition with a high prevalence leading to
emotional abnormality. Despite some drawbacks, depression currently diagnosed using a …

MicroRNAs (miRNAs) are non-encoding, single-stranded RNA molecules of about 22
nucleotides in length encoded by endogenous genes involved in posttranscriptional gene …